Earnings Preview: Key Performance Drivers for CVS Health in 2Q15 CVS Health’s guidance for 2Q15 CVS Health (CVS) expects Retail Pharmacy sales growth between 0.5% and 2% year-over-year in 2Q15. Total same-store sales are expected to be in the range of -1.25% to 0.25%. Adjusted script comps (comparables) growth is projected between 4.25% and 5.25%. This implies segment sales in the region of $16.9–$17.2 billion in the quarter. However, growth is expected to be negatively impacted by last year’s exit from tobacco products. As a result, CVS estimates an 8% decline in front store comps in... More